SEBI Greenlights IHH Healthcare's Open Offer for Fortis Healthcare and Fortis Malar Hospitals
IHH Healthcare Berhad received SEBI approval for open offers to acquire stakes in Fortis Healthcare and Fortis Malar Hospitals. The transaction includes a preferential allotment of 235,294,117 new Fortis shares to IHH's subsidiary, and mandatory open offers for up to 26.10% of Fortis Healthcare and 26.11% of Fortis Malar Hospitals. This approval ends a regulatory delay since 2018, potentially reshaping India's private healthcare sector.

*this image is generated using AI for illustrative purposes only.
In a significant development for the Indian healthcare sector, IHH Healthcare Berhad has received approval from the Securities and Exchange Board of India (SEBI) to proceed with open offers for Fortis Healthcare Limited and its subsidiary, Fortis Malar Hospitals Limited. This approval marks a crucial step forward in a transaction that has been in regulatory limbo since 2018.
Transaction Details
The approved transaction consists of three key components:
Preferential Allotment: IHH's subsidiary, Northern TK Venture Pte Ltd, will subscribe to 235,294,117 new Fortis shares through a preferential allotment.
Fortis Healthcare Open Offer: A mandatory open offer for up to 197,025,660 Fortis shares, representing 26.10% of the expanded voting capital.
Fortis Malar Hospitals Open Offer: A mandatory open offer for up to 4,894,308 Malar shares, representing 26.11% of the voting capital.
Regulatory Approval
SEBI's approval letter allows IHH to move forward with both open offers. This decision comes after a protracted regulatory process that began in 2018, highlighting the complexity and duration of the transaction.
Company Disclosures
Fortis Healthcare Limited, in compliance with SEBI Listing Regulations, disclosed this development to the stock exchanges. The company's announcement references an earlier communication from December 17, 2018, underscoring the extended timeline of this corporate action.
Market Impact
The approval is expected to have significant implications for both Fortis Healthcare and Fortis Malar Hospitals. Investors and market watchers will likely be keen to observe how this development affects the shareholding structure and strategic direction of these healthcare entities.
Looking Ahead
While this approval marks a crucial milestone, the completion of the open offers will be the next key event to watch. Fortis Healthcare has committed to keeping the stock exchanges informed of any material developments in this matter.
As this long-awaited transaction moves forward, it could potentially reshape the landscape of India's private healthcare sector, with IHH Healthcare Berhad poised to strengthen its position in the Indian market.
Shareholders and potential investors of Fortis Healthcare and Fortis Malar Hospitals are advised to monitor further announcements for updates on the progress of these open offers.
Historical Stock Returns for Fortis Healthcare
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.93% | +5.11% | +2.49% | +48.61% | +64.11% | +625.42% |